feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease",https://benzinga.com/general/biotech/22/06/27760074/the-daily-biotech-pulse-addex-terminates-parkinsons-study-expanded-use-of-rhythms-obesity-drug-fd,https://bit.ly/3zHznIL
Benzinga,Here's Why Needham Sees Apple's Brand Value Worth At $1T,https://benzinga.com/news/22/06/27762276/heres-why-needham-sees-apples-value-as-worth-1t,https://bit.ly/3Huz5qx
Benzinga,Overview Of Value Stocks In The Consumer Defensive Sector,https://benzinga.com/news/22/06/27763512/overview-of-value-stocks-in-the-consumer-defensive-sector,https://bit.ly/3HyPV7N
Benzinga,A Look Into Basic Materials Sector Value Stocks,https://benzinga.com/news/22/06/27763464/a-look-into-basic-materials-sector-value-stocks,https://bit.ly/3OqtJil
